•Human inflammatory bowel disease-on-a-chip for modelling disease progression, cancer initiation and sex-specific effects
•Fatty acid oxidation and inflammatory bowel disease: Highlighting the roles of pathogenesis and treatment
•TL1A as a therapeutic renaissance in inflammatory bowel disease: a systematic review from molecular mechanisms to clinical translation
•Imaging in inflammatory bowel disease 2025: ECCO-ESGAR-ESP-IBUS diagnostic and monitoring recommendations with MRI and intestinal ultrasound in treat-to-target strategies
•Dietary protein as a regulator of colitis and colorectal cancer
